143 related articles for article (PubMed ID: 17522244)
1. Commentary: IMRT for head and neck cancer: many chapters left to write.
Allen AM; Tishler RB
Oncologist; 2007 May; 12(5):565-8. PubMed ID: 17522244
[No Abstract] [Full Text] [Related]
2. Intensity-modulated radiation therapy for head and neck carcinoma.
Grégoire V; De Neve W; Eisbruch A; Lee N; Van den Weyngaert D; Van Gestel D
Oncologist; 2007 May; 12(5):555-64. PubMed ID: 17522243
[TBL] [Abstract][Full Text] [Related]
3. Regional relapse after intensity-modulated radiotherapy for head-and-neck cancer.
Duprez F; Bonte K; De Neve W; Boterberg T; De Gersem W; Madani I
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):450-8. PubMed ID: 20381266
[TBL] [Abstract][Full Text] [Related]
4. Intensity-modulated radiation therapy.
Lee NY; Terezakis SA
J Surg Oncol; 2008 Jun; 97(8):691-6. PubMed ID: 18493919
[TBL] [Abstract][Full Text] [Related]
5. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400
[TBL] [Abstract][Full Text] [Related]
6. RapidArc planning and delivery in patients with locally advanced head-and-neck cancer undergoing chemoradiotherapy.
Doornaert P; Verbakel WF; Bieker M; Slotman BJ; Senan S
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):429-35. PubMed ID: 20421159
[TBL] [Abstract][Full Text] [Related]
7. Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy.
Marzi S; Iaccarino G; Pasciuti K; Soriani A; Benassi M; Arcangeli G; Giovinazzo G; Benassi M; Marucci L
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1252-9. PubMed ID: 19251097
[TBL] [Abstract][Full Text] [Related]
8. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer.
Guerrero Urbano T; Clark CH; Hansen VN; Adams EJ; A'Hern R; Miles EA; McNair H; Bidmead M; Warrington AP; Dearnaley DP; Harrington KJ; Nutting CM
Radiother Oncol; 2007 Oct; 85(1):36-41. PubMed ID: 17709149
[TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
[TBL] [Abstract][Full Text] [Related]
10. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302
[TBL] [Abstract][Full Text] [Related]
11. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
[TBL] [Abstract][Full Text] [Related]
12. Proton radiation therapy for head and neck cancer.
Chan AW; Liebsch NJ
J Surg Oncol; 2008 Jun; 97(8):697-700. PubMed ID: 18493920
[TBL] [Abstract][Full Text] [Related]
13. Comparison of IMRT treatment plans between linac and helical tomotherapy based on integral dose and inhomogeneity index.
Shi C; Peñagarícano J; Papanikolaou N
Med Dosim; 2008; 33(3):215-21. PubMed ID: 18674686
[TBL] [Abstract][Full Text] [Related]
14. A dosimetric comparison of proton and intensity-modulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas.
Kozak KR; Adams J; Krejcarek SJ; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):179-86. PubMed ID: 19019562
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with radiation-induced nausea and vomiting in head and neck cancer patients treated with intensity modulated radiation therapy.
Monroe AT; Reddy SC; Gibbs GL; White GA; Peddada AV
Radiother Oncol; 2008 May; 87(2):188-94. PubMed ID: 18237801
[TBL] [Abstract][Full Text] [Related]
16. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144
[TBL] [Abstract][Full Text] [Related]
17. Matching intensity-modulated radiation therapy to an anterior low neck field.
Amdur RJ; Liu C; Li J; Mendenhall W; Hinerman R
Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S46-8. PubMed ID: 17848293
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated radiotherapy for head and neck cancer.
Caglar HB; Allen AM
Clin Adv Hematol Oncol; 2007 Jun; 5(6):425-31. PubMed ID: 17679916
[TBL] [Abstract][Full Text] [Related]
19. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems.
Das IJ; Cheng CW; Chopra KL; Mitra RK; Srivastava SP; Glatstein E
J Natl Cancer Inst; 2008 Mar; 100(5):300-7. PubMed ID: 18314476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
